Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sowmya Viswanathan

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Biofabrication|July 25, 2013
Cross-linked glucose oxidase clusters for biofuel cell anode catalystsJonathan Dudzik, Wen-Chi Chang, A M Kannan, et al.
Transgenic Research|July 12, 2014
Development and characterization of a new inbred transgenic rat strain expressing DsRed monomeric fluorescent proteinSonia Montanari, Xing-Hua Wang, Gustavo Yannarelli, et al.
The FEBS Journal|December 18, 2013
The effect of triple glutamic mutations E9Q/E194Q/E204Q on the structural stability of bacteriorhodopsinTzvetana Lazarova, Krzysztof Mlynarczyk, Slawomir Filipek, et al.
Stem Cell Reviews and Reports|November 30, 2013
Donor mesenchymal stromal cells (MSCs) undergo variable cardiac reprogramming in vivo and predominantly co-express cardiac and stromal determinants after experimental acute myocardial infarctionGustavo Yannarelli, James N Tsoporis, Jean-Francois Desjardins, et al.
Cytotherapy|March 14, 2021
Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predispositionJacques Galipeau, Mauro Krampera, Katarina Leblanc, et al.
Oncotarget|November 29, 2017
A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacyBrent A Williams, Arjun Datt Law, Bertrand Routy, et al.
Haematologica|January 25, 2012
Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse modelBrenna E Swift, Brent A Williams, Yoko Kosaka, et al.
Lab on a Chip|September 18, 2024
Reversible bonding in thermoplastic elastomer microfluidic platforms for harvestable 3D microvessel networksByeong-Ui Moon, Kebin Li, Lidija Malic, et al.
Scientific Reports|January 14, 2018
<sup>19</sup>F-perfluorocarbon-labeled human peripheral blood mononuclear cells can be detected in vivo using clinical MRI parameters in a therapeutic cell settingCorby Fink, Jeffrey M Gaudet, Matthew S Fox, et al.
Stem Cells and Development|January 16, 2014
Soliciting strategies for developing cell-based reference materials to advance mesenchymal stromal cell research and clinical translationSowmya Viswanathan, Armand Keating, Robert Deans, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Biofabrication|July 25, 2013
Cross-linked glucose oxidase clusters for biofuel cell anode catalystsJonathan Dudzik, Wen-Chi Chang, A M Kannan, et al.
Transgenic Research|July 12, 2014
Development and characterization of a new inbred transgenic rat strain expressing DsRed monomeric fluorescent proteinSonia Montanari, Xing-Hua Wang, Gustavo Yannarelli, et al.
The FEBS Journal|December 18, 2013
The effect of triple glutamic mutations E9Q/E194Q/E204Q on the structural stability of bacteriorhodopsinTzvetana Lazarova, Krzysztof Mlynarczyk, Slawomir Filipek, et al.
Stem Cell Reviews and Reports|November 30, 2013
Donor mesenchymal stromal cells (MSCs) undergo variable cardiac reprogramming in vivo and predominantly co-express cardiac and stromal determinants after experimental acute myocardial infarctionGustavo Yannarelli, James N Tsoporis, Jean-Francois Desjardins, et al.
Cytotherapy|March 14, 2021
Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predispositionJacques Galipeau, Mauro Krampera, Katarina Leblanc, et al.
Oncotarget|November 29, 2017
A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacyBrent A Williams, Arjun Datt Law, Bertrand Routy, et al.
Haematologica|January 25, 2012
Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse modelBrenna E Swift, Brent A Williams, Yoko Kosaka, et al.
Lab on a Chip|September 18, 2024
Reversible bonding in thermoplastic elastomer microfluidic platforms for harvestable 3D microvessel networksByeong-Ui Moon, Kebin Li, Lidija Malic, et al.
Scientific Reports|January 14, 2018
<sup>19</sup>F-perfluorocarbon-labeled human peripheral blood mononuclear cells can be detected in vivo using clinical MRI parameters in a therapeutic cell settingCorby Fink, Jeffrey M Gaudet, Matthew S Fox, et al.
Stem Cells and Development|January 16, 2014
Soliciting strategies for developing cell-based reference materials to advance mesenchymal stromal cell research and clinical translationSowmya Viswanathan, Armand Keating, Robert Deans, et al.
Pageof 6